Literature DB >> 8592660

Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis.

N M Volpato1, P Santi, P Colombo.   

Abstract

PURPOSE: Iontophoresis was employed for enhancing the transdermal delivery of acyclovir through nude mouse skin in vitro, with the aim of understanding the mechanisms responsible for drug transport, in order to properly set the conditions of therapeutical application.
METHODS: Experiments were done in horizontal diffusion cells, using as donor a saturated solution of acyclovir at two different pH values (3.0 and 7.4). Different electrical conditions (current density and polarity) were employed.
RESULTS: At pH 3.0, acyclovir anodal transport was due to electrorepulsion, since acyclovir was 20% in the protonated form. In acyclovir anodal iontophoresis at pH 7.4 the main mechanism involved was electroosmosis, since the drug was substantially unionized and the negative charge of the skin at this pH caused the electroosmotic flow to be from anode to cathode. In the case of cathodal iontophoresis at pH 3.0, acyclovir transport was enhanced approx. seven times, due to the presence of an electroosmotic contribution caused by the reversal of the charge of the skin. At pH 7.4 during cathodal iontophoresis acyclovir transport was not enhanced because the electroosmotic flow was in the opposite direction, compared to drug electric transport, i.e. anode to cathode. The increased skin permeability caused by current application was demonstrated to be less important than electrorepulsion and electroosmosis.
CONCLUSIONS: Anodal iontophoresis shows potential applicability for enhancing acyclovir transport to the skin, considering that both electric transport and electroosmosis can be used by appropriately setting the pH of the donor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8592660     DOI: 10.1023/a:1016284815501

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis.

Authors:  R R Burnette; B Ongpipattanakul
Journal:  J Pharm Sci       Date:  1988-02       Impact factor: 3.534

2.  Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

3.  Acyclovir bioavailability in human skin.

Authors:  G E Parry; P Dunn; V P Shah; L K Pershing
Journal:  J Invest Dermatol       Date:  1992-06       Impact factor: 8.551

4.  Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

5.  Convective solvent flow across the skin during iontophoresis.

Authors:  A Kim; P G Green; G Rao; R H Guy
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  Characterization of convective solvent flow during iontophoresis.

Authors:  M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

Review 7.  The role of electroosmotic flow in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

8.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

  8 in total
  9 in total

1.  Transdermal macromolecular delivery: real-time visualization of iontophoretic and chemically enhanced transport using two-photon excitation microscopy.

Authors:  B S Grewal; A Naik; W J Irwin; G Gooris; C J de Grauw; H G Gerritsen; J A Bouwstra
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

2.  The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis.

Authors:  N G Turner; Y N Kalia; R H Guy
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin.

Authors:  Cristina Padula; Francesca Sartori; Fabio Marra; Patrizia Santi
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

4.  Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.

Authors:  Nada Abla; Aarti Naik; Richard H Guy; Yogeshvar N Kalia
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.

Authors:  R van der Geest; M Danhof; H E Boddé
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

6.  Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.

Authors:  Akhmad Kharis Nugroho; Oscar Della Pasqua; Meindert Danhof; Joke A Bouwstra
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

7.  Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.

Authors:  Qingfang Xu; Sarah A Ibrahim; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2008-11-11       Impact factor: 5.875

8.  Electroosmotic flow and its contribution to iontophoretic delivery.

Authors:  Natalie R Herr; Brian M Kile; Regina M Carelli; R Mark Wightman
Journal:  Anal Chem       Date:  2008-10-24       Impact factor: 6.986

9.  Enhancement of transdermal penetration and bioavailability of poorly soluble acyclovir using solid lipid nanoparticles incorporated in gel cream.

Authors:  P S Gide; S K Gidwani; K U Kothule
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.